| CEO Name | Thomas Burns |
| Nationality | United States |
| Net Worth Estimation | $50 million |
Thomas Burns, CEO of Glaukos Corporation, has an estimated net worth of around $50 million primarily due to his long tenure, substantial equity holdings, and stock transactions within the publicly traded company (NYSE: GKOS). His compensation includes salary, bonuses, and significant share-based awards, further boosted by Glaukos' stock performance.
Thomas Burns, CEO of Glaukos Corporation, has an estimated net worth of $50,000,000, which is 10% of the maximum and 500% of the minimum net worth range for pharmaceutical CEOs ($10,000,000-$500,000,000). His net worth places him solidly in the lower-middle of this industry range.
Business Category: Pharmaceutical
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 500000000 USD
Thomas Burns Performance in Glaukos Corporation
Thomas Burns, CEO of Glaukos Corporation, demonstrates strategic leadership in advancing innovative glaucoma treatments. His decisive focus on research and development has driven significant product pipeline expansion and market growth. Under his leadership, Glaukos has strengthened its industry position and delivered consistent financial performance improvements.
Latest News
Glaukos Breaks Ground on $82 Million Research & Manufacturing Campus in Huntsville
Glaukos Corporation, under CEO Tom Burns, has begun constructing a major new research, development, and manufacturing facility in Huntsville, Alabama, expected to create 154 jobs by 2030 as part of an $82 million investment. Burns highlighted Huntsville's strong tech community and workforce as key reasons for choosing the location during the September 2025 groundbreaking ceremony.
Source: http://huntsvillebusinessjournal.com/news/2025/09/29/glaukos-expands-to-huntsville-with-82-million-research-and-manufacturing-campus/